DSpace Repository

Out-of-pocket costs of AIDS care in China: are free antiretroviral drugs enough?

Show simple item record

dc.contributor Médecins Sans Frontières, Beijing, China and Brussels, Belgium. suerie_moon@yahoo.com
dc.creator Moon, S
dc.creator Van Leemput, L
dc.creator Durier, N
dc.creator Jambert, E
dc.creator Dahmane, A
dc.creator Jie, Y
dc.creator Wu, G
dc.creator Philips, M
dc.creator Hu, Y
dc.creator Saranchuk, P
dc.date 2008-09
dc.date.accessioned 2017-01-31T07:12:28Z
dc.date.available 2017-01-31T07:12:28Z
dc.identifier Out-of-pocket costs of AIDS care in China: are free antiretroviral drugs enough? 2008, 20 (8):984-94notAIDS Care
dc.identifier 1360-0451
dc.identifier 18777223
dc.identifier 10.1080/09540120701768446
dc.identifier http://hdl.handle.net/10144/38854
dc.identifier http://fieldresearch.msf.org/msf/handle/10144/38854
dc.identifier AIDS Care
dc.identifier.uri http://dspace.mediu.edu.my:8181/xmlui/handle/10144/38854
dc.description To access this article, click on "Additional Links".
dc.description Financial access to HIV care and treatment can be difficult for many people in China, where the government provides free antiretroviral drugs but does not cover the cost of other medically necessary components, such as lab tests and drugs for opportunistic infections. This article estimates out-of-pocket costs for treatment and care that a person living with HIV/AIDS in China might face over the course of one year. Data comes from two treatment projects run by Médecins Sans Frontières in Nanning, Guangxi Province and Xiangfan, Hubei Province. Based on the national treatment guidelines, we estimated costs for seven different patient profiles ranging from WHO Clinical Stages I through IV. We found that patients face significant financial barriers to even qualify for the free ARV program. For those who do, HIV care and treatment can be a catastrophic health expenditure, with cumulative patient contributions ranging from approximately US$200-3939/year in Nanning and US$13-1179/year in Xiangfan, depending on the patient's clinical stage of HIV infection. In Nanning, these expenses translate as up to 340% of an urban resident's annual income or 1200% for rural residents; in Xiangfan, expenses rise to 116% of annual income for city dwellers and 295% in rural areas. While providing ARV drugs free of charge is an important step, the costs of other components of care constitute important financial barriers that may exclude patients from accessing appropriate care. Such barriers can also lead to undesirable outcomes in the future, such as impoverishment of AIDS-affected households, higher ARV drug-resistance rates and greater need for complex, expensive second-line antiretroviral drugs.
dc.language en
dc.relation http://www.informaworld.com/openurl?genre=article&issn=0954-0121&volume=20&issue=8&spage=984
dc.rights Free access to this article was provided by kind permission of Taylor & Francis
dc.title Out-of-pocket costs of AIDS care in China: are free antiretroviral drugs enough?


Files in this item

Files Size Format View

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record

Search DSpace


Advanced Search

Browse

My Account